Uncategorized

The House Energy and Commerce Committee is backing more moderate reforms to Medicaid. But Republicans’ policy proposals would still result in millions of Americans losing health insurance.

Omada, which offers chronic condition management programs, follows Hinge Health to become the latest digital health firm to brave the public markets in recent months.

The proposal would see the HHS set price targets other countries pay for certain medicines, kicking off a round of discussions with substantial ramifications for drugmakers. It’s likely to be challenged in court, however.

The package revives President Donald Trump’s much-maligned Most Favored Nations rule but goes further into the private markets and beyond, leveraging the patent system, drug importation and more.

By Wednesday, the two countries will charge 10% baseline duties during the period and remove certain retaliatory levies that pushed rates over 100%.

Lexeo wants to more quickly move investigational gene therapy LX2006 into a registrational study and hopes for a potential efficacy readout in 2027.

CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its supply chains.

The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ongoing.

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform patients in the state that the drug is likely to be less effective for them.

Last month, Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.